Sirolimus (Dr. Reddy’s Laboratories Limited)


Welcome to the PulseAid listing for the Sirolimus drug offered from Dr. Reddy’s Laboratories Limited. This Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr. Reddy’s Laboratories Limited
NON-PROPRIETARY NAME: Sirolimus
SUBSTANCE NAME: SIROLIMUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-10-27
END MARKETING DATE: 0000-00-00


Sirolimus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSirolimus from Dr. Reddy’s Laboratories Limited
LABELER NAME: Dr. Reddy’s Laboratories Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2014-10-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55111-653_7fdf31c2-81f5-d5a5-75e7-74225e4f5441
PRODUCT NDC: 55111-653
APPLICATION NUMBER: ANDA201578

Other SIROLIMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingSirolimus
Cadila Healthcare Limitedsirolimus
Cardinal HealthRapamune
Dr. Reddy’s Laboratories LimitedSirolimus
Greenstone LLCSirolimus
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Rapamune
Zydus Pharmaceuticals (USA) Inc.sirolimus